Sponsor:
Sumitomo Pharma Switzerland GmbH
Code:
NCT05862272
Conditions
Uterine Fibroids
Endometriosis
Eligibility Criteria
Sex: Female
Age: 18 - 50
Healthy Volunteers: Not accepted
Interventions
Relugolix Combination Tablet
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations